TSXV - Free Realtime Quote CAD

Quest PharmaTech Inc. (QPT.V)

0.0350
-0.0100
(-22.22%)
As of 11:59:46 AM EDT. Market Open.
Currency in CAD All numbers in thousands
Download
Breakdown
TTM
1/31/2024
1/31/2023
1/31/2022
1/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
892.6450
1,315.8200
834.2160
790.5730
1,070.3460
Operating Income
-892.6450
-1,315.8200
-834.2160
-790.5730
-1,070.3460
Net Non Operating Interest Income Expense
-27.9840
-20.6800
-21.0020
-13.0630
-5.9410
Other Income Expense
-1,165.2090
-1,681.5070
-64,032.9350
-84,234.9380
191,140.7560
Pretax Income
-2,085.8380
-3,018.0070
-64,888.1530
-85,038.5740
190,064.4690
Tax Provision
0
0
0
--
--
Net Income Common Stockholders
-2,085.8380
-3,018.0070
-64,888.1530
-85,038.5750
190,064.4690
Diluted NI Available to Com Stockholders
-2,085.8380
-3,018.0070
-64,888.1530
-85,038.5750
190,064.4690
Basic EPS
-0.01
-0.02
-0.38
-0.51
1.11
Diluted EPS
-0.01
-0.02
-0.38
-0.51
1.11
Basic Average Shares
169,129.2470
169,129.2470
168,395.4680
168,239.2470
167,789.5760
Diluted Average Shares
169,129.2470
169,129.2470
168,395.4680
168,239.2470
167,789.5760
Total Operating Income as Reported
-892.6450
-1,315.8200
-834.2160
--
--
Total Expenses
892.6450
1,315.8200
834.2160
790.5730
1,070.3460
Net Income from Continuing & Discontinued Operation
-2,085.8380
-3,018.0070
-64,888.1530
-85,038.5750
190,064.4690
Normalized Income
-748.5790
-1,682.0590
-3,501.4900
-58,316.4600
170,397.9887
Interest Income
--
--
--
0
1.8250
Interest Expense
27.9840
20.6800
21.0020
13.0630
7.7660
Net Interest Income
-27.9840
-20.6800
-21.0020
-13.0630
-5.9410
EBIT
-2,057.8540
-2,997.3270
-64,867.1510
-85,025.5110
190,072.2350
EBITDA
-2,057.8540
-2,994.3550
-64,853.6650
-84,986.9490
190,111.5420
Reconciled Depreciation
0
2.9720
13.4860
38.5620
39.3070
Net Income from Continuing Operation Net Minority Interest
-2,085.8380
-3,018.0070
-64,888.1530
-85,038.5750
190,064.4690
Total Unusual Items Excluding Goodwill
-1,337.2590
-1,335.9480
-61,386.6630
-26,722.1150
26,757.1160
Total Unusual Items
-1,337.2590
-1,335.9480
-61,386.6630
-26,722.1150
26,757.1160
Normalized EBITDA
-720.5950
-1,658.4070
-3,467.0020
-58,264.8340
163,354.4260
Tax Rate for Calcs
0
0
0
0
0.0003
Tax Effect of Unusual Items
0
0
0
0
7,090.6357
1/31/2021 - 6/3/1998

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

KNE.V Kane Biotech Inc.
0.0750
-6.25%
 
AUPH Aurinia Pharmaceuticals Inc.
7.98
-1.60%
 
HEPA Hepion Pharmaceuticals, Inc.
0.4012
+1.83%
 
PRTA Prothena Corporation plc
7.47
+5.14%
 
TGTX TG Therapeutics, Inc.
33.78
-0.25%